These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 29191507)
21. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies. Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797 [TBL] [Abstract][Full Text] [Related]
22. Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties. Barrera LN; Evans A; Lane B; Brumskill S; Oldfield FE; Campbell F; Andrews T; Lu Z; Perez-Mancera PA; Liloglou T; Ashworth M; Jalali M; Dawson R; Nunes Q; Phillips PA; Timms JF; Halloran C; Greenhalf W; Neoptolemos JP; Costello E Cancer Res; 2020 Jul; 80(13):2861-2873. PubMed ID: 32393661 [TBL] [Abstract][Full Text] [Related]
23. [Epithelial-stromal interactions in pancreatic adenocarcinoma: the role of stroma in disease progression]. Kuznetsova AV; Popova OP; Astakhov DA; Ivanov YV; Panchenkov DN; Ivanov AA Arkh Patol; 2022; 84(5):65-70. PubMed ID: 36178225 [TBL] [Abstract][Full Text] [Related]
24. Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer. Lodestijn SC; Miedema DM; Lenos KJ; Nijman LE; Belt SC; El Makrini K; Lecca MC; Waasdorp C; van den Bosch T; Bijlsma MF; Vermeulen L Cell Rep; 2021 Oct; 37(3):109852. PubMed ID: 34686335 [TBL] [Abstract][Full Text] [Related]
25. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Ene-Obong A; Clear AJ; Watt J; Wang J; Fatah R; Riches JC; Marshall JF; Chin-Aleong J; Chelala C; Gribben JG; Ramsay AG; Kocher HM Gastroenterology; 2013 Nov; 145(5):1121-32. PubMed ID: 23891972 [TBL] [Abstract][Full Text] [Related]
26. Development of a novel co-culture system using human pancreatic cancer cells and human iPSC-derived stellate cells to mimic the characteristics of pancreatic ductal adenocarcinoma in vitro. Kometani T; Kamo K; Kido T; Hiraoka N; Chibazakura T; Unno K; Sekine K Biochem Biophys Res Commun; 2023 May; 658():1-9. PubMed ID: 37004297 [TBL] [Abstract][Full Text] [Related]
29. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer. Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719 [No Abstract] [Full Text] [Related]
30. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma. Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030 [TBL] [Abstract][Full Text] [Related]
31. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver. Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299 [TBL] [Abstract][Full Text] [Related]
32. Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma. Sperb N; Tsesmelis M; Wirth T Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752017 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of CD90 (Thy-1) in pancreatic adenocarcinoma present in the tumor microenvironment. Zhu J; Thakolwiboon S; Liu X; Zhang M; Lubman DM PLoS One; 2014; 9(12):e115507. PubMed ID: 25536077 [TBL] [Abstract][Full Text] [Related]
35. Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment. Lin CC; Korc M Cancer Lett; 2018 Nov; 436():22-27. PubMed ID: 30118843 [TBL] [Abstract][Full Text] [Related]
36. The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells. Kung PJ; Lai TY; Cao J; Hsu LC; Chiang TC; Ou-Yang P; Tsai CY; Tsai YF; Lin CW; Chen CC; Tsai MK; Tien YW; Lee CY Cancer Immunol Immunother; 2022 Mar; 71(3):705-718. PubMed ID: 34374812 [TBL] [Abstract][Full Text] [Related]
37. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors. Djurec M; Graña O; Lee A; Troulé K; Espinet E; Cabras L; Navas C; Blasco MT; Martín-Díaz L; Burdiel M; Li J; Liu Z; Vallespinós M; Sanchez-Bueno F; Sprick MR; Trumpp A; Sainz B; Al-Shahrour F; Rabadan R; Guerra C; Barbacid M Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1147-E1156. PubMed ID: 29351990 [TBL] [Abstract][Full Text] [Related]
38. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications. Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007 [TBL] [Abstract][Full Text] [Related]
39. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. Ma Y; Hwang RF; Logsdon CD; Ullrich SE Cancer Res; 2013 Jul; 73(13):3927-37. PubMed ID: 23633481 [TBL] [Abstract][Full Text] [Related]
40. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. Ijichi H; Chytil A; Gorska AE; Aakre ME; Bierie B; Tada M; Mohri D; Miyabayashi K; Asaoka Y; Maeda S; Ikenoue T; Tateishi K; Wright CV; Koike K; Omata M; Moses HL J Clin Invest; 2011 Oct; 121(10):4106-17. PubMed ID: 21926469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]